We are live on ! Find out more
RXL icon

ProShares Ultra Health Care

16 hedge funds and large institutions have $6.16M invested in ProShares Ultra Health Care in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

1% more capital invested

Capital invested by funds: $6.11M → $6.16M (+$52.5K)

7.68% less ownership

Funds ownership: 36.94%29.26% (-7.7%)

11% less funds holding

Funds holding: 1816 (-2)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

Holders
16
Holders Change
-2
Holders Change %
-11.11%
% of All Funds
0.4%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
2
Reduced
5
Closed
5
Calls
Puts
Net Calls
Net Calls Change

RXL Hedge Fund Activity: Q1 2017 in Review

16 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in ProShares Ultra Health Care (RXL) for Q1 2017, worth a combined $6.16M — up 0.86% from $6.11M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of RXL and 3 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 2 added.

The largest buyer was Susquehanna International Group, adding an estimated $217K. The largest seller was Goldman Sachs, exiting entirely with an estimated $316K sold.

  • 16 institutional investors held ProShares Ultra Health Care (RXL) as of Q1 2017, down from 18 in Q4 2016.
  • Funds reported $6.16M of ProShares Ultra Health Care stock for Q1 2017, up 0.86% quarter-over-quarter.
  • 3 funds opened new ProShares Ultra Health Care positions in Q1 2017 and 5 closed out, a net change of -2 holders.
  • The largest ProShares Ultra Health Care buyer in Q1 2017 was Susquehanna International Group, an estimated $217K added.
  • The largest ProShares Ultra Health Care seller in Q1 2017 was Goldman Sachs, an estimated $316K sold.

Based on aggregated 13F filings for Q1 2017.